LAGOS POLICE LAUNCH INVESTIGATION AS JEWELLER ACCUSES ITS OFFICERS OF HARASSMENT. (PHOTO).
Alert on recall of Sibutramine containing products in Asia.
#NafdacALERTS
https://bit.ly/4dQ16s9
NAFDAC is notifying the public of the recall of some sibutramine-containing products by three regulatory bodies in Asia due to the increased risk of cardiovascular diseases and stroke in users.
Sibutramine is an appetite suppressant previously authorized for the treatment of obesity but has been withdrawn from sale by the manufacturers and its licenses suspended by the European Medicines Agency (EMA) in 2010 based on new safety information discovered from a reviewed study of the medicine. It was discovered from the review that the risk of sibutramine outweighs its benefits due to its link to cardiovascular events (such as heart attack and stroke). Weight control should be achieved through healthy lifestyle measures like eating healthy and appropriate exercise.
Although the products are not in the NAFDAC database, they are mostly marketed as “effective weight loss supplements”, and illegally sold online through social media platforms like Instagram.
Importers, distributors, retailers, and consumers are advised to exercise caution and vigilance within the supply chain to avoid the importation, distribution, sale, and use of the above-mentioned products. Members of the public in possession of any of the products should discontinue the sale or use and submit stock to the nearest NAFDAC office.
More photos below.
Comments
Post a Comment